These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4634511)

  • 21. New drug and antibiotic regulations--FDA. Proposed rule.
    Fed Regist; 1982 Oct; 47(202):46622-66. PubMed ID: 10262075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct-to-consumer advertising affects provider / patient relationship.
    Contracept Technol Update; 1998 Dec; 19(12):153-5. PubMed ID: 12321805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A physician's prerogative to prescribe drugs for off-label uses during pregnancy.
    Rayburn WF
    Obstet Gynecol; 1993 Jun; 81(6):1052-5. PubMed ID: 8497349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Special report: the truth about condoms. Will your clients want the plastic condom?
    Contracept Technol Update; 1995 Jan; 16(1):6-9. PubMed ID: 12319321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population.
    Wen SW; Yang T; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Walker MC
    J Perinatol; 2008 May; 28(5):324-9. PubMed ID: 18288118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of cardiovascular drugs: the U.S. regulatory milieu from the perspective of a participating nonregulator.
    Borer JS
    J Am Coll Cardiol; 2004 Dec; 44(12):2285-92. PubMed ID: 15607388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Government regulations and the use of drugs.
    Hafkenschiel JH
    Calif Med; 1967 Aug; 107(2):159-63. PubMed ID: 4862066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The ANMCO (National Association of Hospital Cardiologists) in a changing health care system. Consensus development of the Organizing Symposium of the XXXI National Congress of Cardiology--ANMCO; Florence, May 21, 2000].
    Ital Heart J Suppl; 2000 Dec; 1(12):1533-44. PubMed ID: 11221582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General administrative rulings and decisions; amendment to the examination and investigation sample requirements; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep; 63(186):51322-4. PubMed ID: 10185811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs.
    Yang J; Xie R; Krewski D; Wang Y; Walker M; Cao W; Wen SW
    Chin Med J (Engl); 2014; 127(4):702-6. PubMed ID: 24534226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing patient autonomy through peer review to replace the FDA's rigorous approval process.
    Caplan A
    Health Aff (Millwood); 2012 Oct; 31(10):2236-40. PubMed ID: 23048103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication considerations.
    Collopy KT
    EMS Mag; 2010 Jul; 39(7):65-6, 68-70. PubMed ID: 20687419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.